Literature DB >> 21125333

Proteomic identification of differentially-expressed proteins in esophageal cancer in three ethnic groups in Xinjiang.

Zan Liu1, Jun-Guo Feng, Aerziguli Tuersun, Tao Liu, Hui Liu, Qing Liu, Shu-Tao Zheng, Cong-Gai Huang, Guo-Dong Lv, Ilyar Sheyhidin, Xiao-Mei Lu.   

Abstract

The Objective is to identify candidate biomarkers for Squamous cell carcinoma (ESCC) in three ethnics in Xinjiang as well as reveal molecular mechanism. Proteins from 15 pairs of ESCC and matching adjacent normal esophageal tissues (five pairs in each ethnic of Kazakh, Uygur and Han) were separated by 2-DE and differentially proteins were identified by matrix-assisted laser desorption/ionization time-of-flight MS. After identified by Mascot database, some of interesting proteins were confirmed in the other 175 pairs of ESCC by immuno histochemistry. Comparison of patterns revealed 20 proteins significantly changed, of which 12 protein with concordantly increased, such as ACTB protein, COMT protein, Syntaxin binding protein Pyruvate Kinase (PKM2), Cathepsin D, Chromosome 1 open reading frame 8, Heat shock protein 27, Cdc42, Proteosome, LLDBP, Immunoglobulin, TNF receptor associated factor 7; and eight protein spots with concordantly decreased intensity in ESCC, such as Adenylate kinase 1, General transcription factor II H, Smooth muscle protein, Trangelin, Early endosome antigen 1, Annexin A2, Fibrin beta, Tropomyosin. There were a significant difference in protein overexpression of PKM2 (74.9%) and Cathepsin D (85.1%) in ESCC compared to adjacent tissues (P < 0.05) by immunohistochemistry. Further, overexpression of Cathepsin D was obvious difference in Hazakh ESCC (94.7%) than that in Uygur (78.6%) (P < 0.05). Interestingly, the overexpression of Cathepsin D was reversely associated with ESCC differentiation (P < 0.05). Twenty proteins differentially-expressed between ESCC and normal tissues were identified. Cathepsin D and PKM2 were for the first time observed to be dysregulated in Kazakh's ESCC. Moreover, Cathepsin D may play a complicated role both in carcinogenesis and cell-differentiation of ESCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21125333     DOI: 10.1007/s11033-010-0586-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  25 in total

1.  Proteome analysis identifies novel protein candidates involved in regeneration of the cerebellum of teleost fish.

Authors:  Marianne M Zupanc; Ursula M Wellbrock; Günther K H Zupanc
Journal:  Proteomics       Date:  2006-01       Impact factor: 3.984

2.  The tumor marker tumor M2-PK: an application in the diagnosis of gastrointestinal cancer.

Authors:  G Schulze
Journal:  Anticancer Res       Date:  2000 Nov-Dec       Impact factor: 2.480

Review 3.  Molecular biology of esophageal cancer in the genomics era.

Authors:  King F Kwong
Journal:  Surg Clin North Am       Date:  2005-06       Impact factor: 2.741

4.  Tumor M2-pyruvate kinase in lung cancer patients: immunohistochemical detection and disease monitoring.

Authors:  Joachim Schneider; Kathleen Neu; Helmut Grimm; Hans-Georg Velcovsky; Gunter Weisse; Erich Eigenbrodt
Journal:  Anticancer Res       Date:  2002 Jan-Feb       Impact factor: 2.480

5.  Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).

Authors:  H W Wechsel; E Petri; K H Bichler; G Feil
Journal:  Anticancer Res       Date:  1999 Jul-Aug       Impact factor: 2.480

6.  Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma.

Authors:  M Oka; K Yamamoto; M Takahashi; M Hakozaki; T Abe; N Iizuka; S Hazama; K Hirazawa; H Hayashi; A Tangoku; K Hirose; T Ishihara; T Suzuki
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

7.  Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China.

Authors:  Gina D Tran; Xiu-Di Sun; Christian C Abnet; Jin-Hu Fan; Sanford M Dawsey; Zhi-Wei Dong; Steven D Mark; You-Lin Qiao; Philip R Taylor
Journal:  Int J Cancer       Date:  2005-01-20       Impact factor: 7.396

Review 8.  The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer.

Authors:  R Lambert; P Hainaut
Journal:  Best Pract Res Clin Gastroenterol       Date:  2007       Impact factor: 3.043

9.  Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis.

Authors:  Weijie Liu; Yanlei Ma; Long Huang; Jiayuan Peng; Peng Zhang; Huizhen Zhang; Jie Chen; Huanlong Qin
Journal:  Mol Biol Rep       Date:  2009-10-16       Impact factor: 2.316

10.  Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma.

Authors:  Babita Kaura; Rashmi Bagga; Feruza D Patel
Journal:  J Obstet Gynaecol Res       Date:  2004-06       Impact factor: 1.730

View more
  14 in total

Review 1.  Molecular alterations and clinical relevance in esophageal squamous cell carcinoma.

Authors:  Li Shang; Mingrong Wang
Journal:  Front Med       Date:  2013-09-03       Impact factor: 4.592

2.  Clinicopathological pattern and Annexin A2 and Cdc42 status in patients presenting with differentiation and lymphnode metastasis of esophageal squamous cell carcinomas.

Authors:  Jun-Guo Feng; Qing Liu; Xu Qin; Yue-Hua Geng; Shu-Tao Zheng; Tao Liu; Ilyar Sheyhidin; Xiao-Mei Lu
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

3.  Correlations of ALDH2 rs671 and C12orf30 rs4767364 polymorphisms with increased risk and prognosis of esophageal squamous cell carcinoma in the Kazak and Han populations in Xinjiang province.

Authors:  Pan Liu; Hua-Rong Zhao; Fang Li; Lei Zhang; Hua Zhang; Wen-Ran Wang; Rui Mao; Wei-Peng Su; Yang Zhang; Yong-Xing Bao
Journal:  J Clin Lab Anal       Date:  2017-05-02       Impact factor: 2.352

4.  RNA Sequencing of Tumor-Educated Platelets Reveals a Three-Gene Diagnostic Signature in Esophageal Squamous Cell Carcinoma.

Authors:  Tiejun Liu; Xin Wang; Wei Guo; Fei Shao; Zitong Li; Yang Zhou; Zhihong Zhao; Liyan Xue; Xiaoli Feng; Yin Li; Fengwei Tan; Kai Zhang; Qi Xue; Shugeng Gao; Yibo Gao; Jie He
Journal:  Front Oncol       Date:  2022-05-09       Impact factor: 5.738

5.  Serum differential protein identification of Xinjiang Kazakh esophageal cancer patients based on the two-dimensional liquid-phase chromatography and LTQ MS.

Authors:  Cui Li; Guo Xia; Zhang Jianqing; Yang Mei; Bai Ge; Zhang Li
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

6.  M2 isoform of pyruvate kinase (PKM2) is upregulated in Kazakh's ESCC and promotes proliferation and migration of ESCC cells.

Authors:  Qing Liu; Meng Liang; Tao Liu; Lucine Vuitton; Shutao Zheng; Xiangpeng Gao; Mang Lu; Xiuling Li; Ilyar Sheyhidin; Xiaomei Lu
Journal:  Tumour Biol       Date:  2015-09-24

7.  Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro.

Authors:  Sujuan Yuan; Tiankui Qiao; Xibing Zhuang; Wei Chen; Na Xing; Qi Zhang
Journal:  Yonsei Med J       Date:  2016-11       Impact factor: 2.759

8.  Proteomic analysis indicates the importance of TPM3 in esophageal squamous cell carcinoma invasion and metastasis.

Authors:  Shao-Bin Yu; Qin Gao; Wen-Wei Lin; Ming-Qiang Kang
Journal:  Mol Med Rep       Date:  2017-01-25       Impact factor: 2.952

9.  Comparative proteome analysis of human esophageal cancer and adjacent normal tissues.

Authors:  Rezvan Yazdian-Robati; Homa Ahmadi; Maryam Matbou Riahi; Parisa Lari; Seyed Amir Aledavood; Marzieh Rashedinia; Khalil Abnous; Mohammad Ramezani
Journal:  Iran J Basic Med Sci       Date:  2017-03       Impact factor: 2.699

10.  Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis.

Authors:  Haiyan Zhu; Hui Luo; Xuejie Zhu; Xiaoli Hu; Lihong Zheng; Xueqiong Zhu
Journal:  Oncotarget       Date:  2017-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.